Markets report: Aryzta continues slide in Dublin; Bank of Ireland, Ryanair fall

Deal between makers of EpiPens and Viagra will create group with global annual revenues worth €18bn

Deal would cover former blockbuster brands like Lipitor and Viagra, both made in Ireland

Markets report: Airbus rises after strong delivery numbers, Superdry slumps to a loss

Dalata and Ryanair both lost ground, while Irish banking stocks were in favour

Ibec to host its European election debates and IFG shareholders vote on takeover

Shares in British maker of opioid addiction treatment Suboxone fell more than 70%

This Week: Big week for banks as SME lending stays weak amid Brexit caution

Lobbyists call for extending use of cheaper ‘copycat’ drugs where available

National Analytics Conference takes place in Dublin, results due from Liberty Media

Policy of switching to biosimilar drugs never adopted

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Company plans to introduce generic version of Humira either later this year or early in 2019

Markets report: Iseq down almost 0.8% as Aryzta hits fresh low

Generic drugs giant falls far short of Wall Street forecasts with second-quarter profit

Figures for car sales in July to give pointer to performance for remainder of year

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Drugmaker says approving more biosimilar drugs for use here could save the State €140m a year

The public can’t continue to pay for the inaction of policymakers

Biopharma firm Gilead unsuccessful in patent row over its pre-exposure prophylaxis drug